Whitehawk Therapeutics (WHWK) Prepaid Assets (2010 - 2026)
Whitehawk Therapeutics (WHWK) reported Prepaid Assets of $2.5 million for Q1 2026, up 61.4% year-over-year from $1.6 million in Q1 2025, and down 24.46% on a QoQ basis from $3.3 million in Q4 2025.
Whitehawk Therapeutics (WHWK) has 16 years of Prepaid Assets data on file, last reported at $2.5 million in Q1 2026.
- Quarterly Prepaid Assets rose 61.4% year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (up 61.4% YoY) and the FY2025 annual result came in at $3.3 million, up 16.93% from the prior year.
- Prepaid Assets fell to $2.5 million in Q1 2026 per WHWK's latest filing, from $3.3 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $4.4 million in Q1 2023 and bottomed at $1.5 million in Q2 2025.
- The 5-year median for Prepaid Assets is $2.9 million (2022), against an average of $3.0 million.
- The widest annual swing landed in 2022, when Prepaid Assets jumped 1012.88%; it then sank 54.79% in 2025.
- Tracing WHWK's Prepaid Assets over 5 years: stood at $3.7 million in 2022, then grew by 2.14% to $3.8 million in 2023, then dropped by 25.88% to $2.8 million in 2024, then gained by 16.93% to $3.3 million in 2025, then slipped by 24.46% to $2.5 million in 2026.
- Per Business Quant, the three latest WHWK Prepaid Assets figures stand at $2.5 million (Q1 2026), $3.3 million (Q4 2025), and $2.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.51 Mn |
| Dec 31, 2025 | 3.32 Mn |
| Sep 30, 2025 | 2.44 Mn |
| Jun 30, 2025 | 1.47 Mn |
| Mar 31, 2025 | 1.55 Mn |
| Dec 31, 2024 | 2.84 Mn |
| Sep 30, 2024 | 2.69 Mn |
| Jun 30, 2024 | 2.42 Mn |
| Mar 31, 2024 | 3.43 Mn |
| Dec 31, 2023 | 3.83 Mn |
| Sep 30, 2023 | 4.22 Mn |
| Jun 30, 2023 | 2.90 Mn |
| Mar 31, 2023 | 4.39 Mn |
| Dec 31, 2022 | 3.75 Mn |
| Sep 30, 2022 | 3.86 Mn |
| Jun 30, 2022 | 2.81 Mn |
| Mar 31, 2022 | 2.86 Mn |
| Dec 31, 2021 | 2.28 Mn |
| Sep 30, 2021 | 643,000.00 |
| Jun 30, 2021 | 578,461.00 |
| Mar 31, 2021 | 257,081.00 |
| Dec 31, 2020 | 81,000.00 |
| Sep 30, 2020 | 455,855.00 |
| Jun 30, 2020 | 307,400.00 |
| Mar 31, 2020 | 228,662.00 |
| Dec 31, 2019 | 734,785.00 |
| Sep 30, 2019 | 876,492.00 |
| Jun 30, 2019 | 368,048.00 |
| Mar 31, 2019 | 340,414.00 |
| Dec 31, 2018 | 754,392.00 |
| Sep 30, 2018 | 895,091.00 |
| Jun 30, 2018 | 213,461.00 |
| Mar 31, 2018 | 388,505.00 |
| Dec 31, 2017 | 322,221.00 |
| Sep 30, 2017 | 621,807.00 |
| Jun 30, 2017 | 311,064.00 |
| Mar 31, 2017 | 602,488.00 |
| Dec 31, 2016 | 353,434.00 |
| Mar 31, 2014 | 625.00 |
| Dec 31, 2013 | 2,500.00 |
| Sep 30, 2013 | 4,375.00 |
| Mar 31, 2013 | 1,125.00 |
| Dec 31, 2012 | 3,500.00 |
| Sep 30, 2012 | 5,875.00 |
| Jun 30, 2012 | 6,250.00 |
| Mar 31, 2012 | 625.00 |
| Dec 31, 2011 | 2,500.00 |
| Sep 30, 2011 | 4,375.00 |
| Jun 30, 2011 | 6,250.00 |
| Dec 31, 2010 | 2,500.00 |